COE BRIAN (Chief Executive Officer) reported 3 transactions at TALIS BIOMEDICAL CORP
Review the transaction codes below to understand the nature of each event.
Filed: 2/19/2021ACC: 0001209191-21-012510
DirectorOfficer· Chief Executive Officer
Since Feb 2021
-13.30K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
6
Total transactions
30.93K acquired · 44.23K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+15.08K
Price / share
—
Trade value
—
% of position
590.3%
2/17/2021
2.56K→17.64K
Common Stock
Indirect
Shares
+8.42K
Price / share
—
Trade value
—
% of position
47.7%
2/17/2021
17.64K→26.05K
Common Stock
Indirect
Shares
+7.43K
Price / share
—
Trade value
—
% of position
28.5%
2/17/2021
26.05K→33.49K
Total
Net shares
+30.93K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/17/2021 | C · Conversion | +15.08K | — | — | 590.3% | 2.56K | 17.64K |
| Common Stock Indirect | 2/17/2021 | C · Conversion | +8.42K | — | — | 47.7% | 17.64K | 26.05K |
| Common Stock Indirect | 2/17/2021 | C · Conversion | +7.43K | — | — | 28.5% | 26.05K | 33.49K |
| Total | +30.93K | $0.00 | ||||||
Derivative Transactions3
Series C-1 Preferred Stock
Indirect
Converts to
Common Stock
15.08K shares
Shares
−21.57K
Strike price
Held after
0.00
Exercisable
—
2/17/2021
Series E-1 Preferred Stock
Indirect
Converts to
Common Stock
8.42K shares
Shares
−12.04K
Strike price
Held after
0.00
Exercisable
—
2/17/2021
Series F-1 Preferred Stock
Indirect
Converts to
Common Stock
7.43K shares
Shares
−10.63K
Strike price
Held after
0.00
Exercisable
—
2/17/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C-1 Preferred Stock Indirect | Common Stock15.08K shares | 2/17/2021 | C · Conversion | −21.57K | — | 0.00 | |
| Series E-1 Preferred Stock Indirect | Common Stock8.42K shares | 2/17/2021 | C · Conversion | −12.04K | — | 0.00 | |
| Series F-1 Preferred Stock Indirect | Common Stock7.43K shares | 2/17/2021 | C · Conversion | −10.63K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned3.92K
Common Stock
IndirectShares owned3.92K
Common Stock
DirectShares owned58.88K
Total
58.88K direct·7.83K indirect66.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.92K | Indirect |
| Common Stock | 3.92K | Indirect |
| Common Stock | 58.88K | Direct |
| Total | 66.71K | 58.88K direct·7.83K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported